SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

CEO Angelos Stergious next chapter remarks have fueled buyout speculation, while traders are focused on the Phase 3 REGAL AML trials pending 80th-event trigger and eventual results; no acquisition or data leak is confirmed. The rebound has drawn bullish calls, but others view it as volatile, news-free trading and stress that the trial outcome remains uncertain.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly earnings report is the main focus, with traders watching guidance, subscriber engagement and advertising growth amid a steep share-price decline. Bears point to content concerns, competition and past post-earnings drops, while bulls argue low expectations and a stronger outlook could support a rebound.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IRENs steep selloff is being discussed amid broader neocloud concerns about financing, AI infrastructure spending returns, and whether providers can remain independent; traders also point to dilution and possible project delays. The community is split between bearish views that the weakness may persist and bullish arguments that IRENs cash-funded data centers and customer prepayments distinguish it from more debt-heavy peers.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is selling off despite a quarterly earnings beat as investors focus on a narrowed full-year profit outlook with its midpoint unchanged; the new buyback and stronger cash-flow outlook have not offset that concern. Traders are split between buying the dip on capital returns and value, and expecting more downside over cautious guidance and demand pressures.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs Q3 earnings and guidance are dominating discussion, especially whether AI and data-center growth can support heavy capital spending and a return to profitability. Traders are divided between expecting a strong report and worrying that rising spending, financing needs, and an approaching share unlock could weigh on the stock.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

SRPT is rising alongside a broader biotech rebound, while traders also cite the Silence Therapeutics acquisition as a positive read-through for demand for siRNA therapiesa platform in Sareptas pipeline. The community is split on whether the move reflects sector strength or stock-specific buying, with upcoming DM1 and FSHD data adding to optimism but no new Sarepta catalyst confirmed.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is drawing attention as traders position around the full Phase 3 melanoma results for its personalized cancer vaccine, intismeran, with Merck; the prior positive topline result has fueled a sharp rally. Bulls see validation of a broader oncology platform, while skeptics warn that expectations and valuation are stretched and debate a possible sell-the-news reaction.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas sharp selloff is being tied by traders to uncertainty around a potential Monee listing and the planned Sea Cloud launch, with concerns about spending and competition adding to the pressure. Some see the moves as an overreaction and remain positive on Seas growth and business fundamentals, while others fear the new initiatives could weigh on the stock.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabets weak price action and difficulty sustaining rebounds dominate discussion, with traders linking pressure to the broader tech and AI selloff and weighing cloud growth against heavy AI spending and cash-flow concerns ahead of earnings. Bulls see the pullback as a buying opportunity, while bears point to technical weakness and capex risks.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is drawing attention after a sharp post-earnings selloff despite beating expectations, as investors focused on slower U.S. da Vinci procedure growth and a cautious outlook. Traders are split between viewing the decline as an overreaction given the companys robotic-surgery position and recurring revenue, and seeing valuation, competition, and growth uncertainty as reasons for a reset.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

Basel Medical Group (NASDAQ:BMGL) stock moved upwards by 14.1% to $4.68 during Wednesday's after-market session. The market value of their outstanding shares is at $8.3 million.
Alaunos Therapeuticsread more...

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers

Basel Medical Group (NASDAQ:BMGL) shares moved upwards by 59.8% to $7.32 during Monday's regular session.
Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 45.18% to $2.41. The company'sread more...

Five Stories Putting Traders on Notice: Insider Buying, FDA Catalysts, Psychedelic Breakthroughs and a U.S. Tungsten Rush

The market is once again rewarding investors willing to look beyond the headline indexes; NeOnc Technologies Holdings (NASDAQ:NTHI), Armata Pharmaceuticals (NYSEAMERICAN:ARMP), Definium Therapeutics (NASDAQ:DFTX), Basel Medical Group (NASDAQ:BMGL), Blue Moon Metals (NASDAQ:BMM) and The Elmet Group (NASDAQ:ELMT).

Why Did BMGL Stock Slump 18% Today?

Equity

Basel Medical Group’s board of directors approved a 1-for-12 reverse stock split, the first share consolidation in the company’s history.

Rosen Law Firm Encourages Basel Medical Group Ltd. Investors to Inquire About Securities Class Action Investigation BMGL

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Basel Medical Group Ltd. (NASDAQ: BMGL) resulting from allegations that Basel Medical may have issued materially misleading business information to the...

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

Basel Medical Group Ltd.

Bullish Sentiment

<ul class="summary-bullets"><li>The reverse stock split will take effect on June 22, 2026.</li><li>The move will reduce the number of outstanding shares from about 18.8 million to roughly 1.57 million.</li><li>The stock currently has a short interest of 0.1%, its lowest in a year.</li></ul>Shares of Basel Medical Group (BMGL) slumped more than 18% on Wednesday, reversing three sessions of gains, after the company said its board of directors approved a 1-for-12 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement of $1 per share.The reverse stock split will take effect on June 22, 2026. It will be the firm’s first-ever share consolidation.<h2 class="st-heading-2">BMGL To Consolidate 18.8M Shares To Roughly 1.6M Shares</h2>Under the reverse split, every 12 existing shares will be automatically consolidated into one share, reducing the number of outstanding shares from about 18.8 million to roughly 1.57 million. No fractional shares will be issued, the company added.In January, Basel Medical Group received a notice from Nasdaq stating that its shares had traded below the required minimum bid price of $1 for 30 consecutive business days. The company was given 180 days, or until July 21, 2026, to regain compliance.According to its latest income statement for the year ended June 2025, the company reported a net loss of $8.4 million, compared with a loss of $1.5 million a year earlier. The stock currently has a short interest of 0.1%, its lowest in a year.<h2 class="st-heading-2">What Is Retail’s Take On BMGL?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/BMGL">BMGL</a> on Stocktwits turned ‘bullish’ from ‘extremely bullish’ a day earlier, while message volumes were ‘extremely high.’Investors saw the dip as an opportunity to buy, with one investor expecting a 20% to 50% return.<stembedurl>https://stocktwits.com/Sele/message/656023604</stembedurl>The stock has shed around 4% of its value so far this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/cbrl-stock-gains-wall-street-upside-potential-high-short-interest/cZ06ql1R7c4">CBRL Stock On Track To Post Best Single-Day Gains – Wells Fargo Says Cheap Valuation, 27% Short Interest Set Stage For Further Upside</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

S&P 500 Index trades listlessly ahead of Nvidia earnings. 

Basel Medical Group Ltd

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

) reports earnings after the close today. What do you expect?

Stocktwits Polls

$BMGL priced a $7.98 million private placement of 6 million units at $1.33 each, netting about $7.28 million for working capital and M&A.

jorge .miguel

$BMGL Current Float is at 700K only which would make it move very fast on volume.  
  
Would not even be stunned if they squeeze it back to 8-7$ range. Keep this on your radar.

CasualTradeer

$BMGL While that may be true there’s no upcoming catalysts here although I’d love to be wrong 💸💸💸

Feed

News

Sentiment

Fundamentals

Info

BMGL Basel Medical Group Ltd

Fundamentals

Latest BMGL News